Our findings on the ability of miR-222 for regulating the expression of PCSK9, a LDLR negative regulator, is in line with its formerly identified roles in lipid metabolic diseases and susceptibility for developing obesity and heart failure. The gene discussed is PCSK9; the disease is obesity due to melanocortin 4 receptor deficiency.